Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;30(13):8669-8670.
doi: 10.1245/s10434-023-14411-5. Epub 2023 Oct 11.

ASO Author Reflections: Active Surveillance and Desmoid

Sylvie Bonvalot  1 , Sarah Watson  2
Affiliations
Comment

ASO Author Reflections: Active Surveillance and Desmoid

Sylvie Bonvalot et al. Ann Surg Oncol. 2023 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34:462–8. - DOI - PubMed
    1. Bonvalot S, Cozic N, Le Cesne A, et al. Initial active surveillance strategy for patients with peripheral sporadic primary desmoid-type fibromatosis: A multicentric phase 2 observational trial. Ann Surgic Oncol. 2023. https://doi.org/10.1245/s10434-023-14341-2 . - DOI
    1. Colombo C, Fiore M, Grignani G, et al. A prospective observational study of active surveillance in primary desmoid fibromatosis. Clin Cancer Res. 2022;28(18):4027–32. - DOI - PubMed
    1. Schut AW, Timbergen MJM, van Broekhoven DLM, et al. A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis: The GRAFITI trial. Ann Surg. 2023;277(4):689–96. - DOI - PubMed
    1. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med. 2018;379:2417–28. - DOI - PubMed - PMC

LinkOut - more resources